Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02129192
Brief Title: Bioequivalence Study of Telmisartan Between Telmisartan 80 mg/Amlodipine 5 mg/Hydrochlorothiazide 12.5 mg (T80/A5/H12.5 mg) Fixed-dose Combination (FDC) Tablet and T80/H12.5 mg Tab and A5 mg (Encap A2.5 mg Tab x2) Concomitant Use

First Submitted : April 30, 2014
First Submitted that Met QC Criteria : April 30, 2014
First Posted : May 2, 2014 (Estimate)

Results First Submitted : October 6, 2016
Results First Submitted that Met QC Criteria : March 1, 2017
Results First Posted : April 12, 2017

Last Update Submitted that Met QC Criteria : March 1, 2017
Last Update Posted : April 12, 2017